CTRI/2019/04/018564进行中（未招募）1 期
An Open Label Clinical trial to assess the Safety and Efficacy of CV-HFT01 tablets as Adjuvant Therapy in patients with hypothyroidism - CV-HFT01
Climic Health Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Male and Female subjects of age 18 to 50 years (both inclusive) and willing to give written inform Consent
- •2. No Significant Medical History
- •3. Ability to understand the risks and benefits of the protocol
- •4. Subject With T3, T4 within Normal Range and TSH to be more than normal ( >4.5 u IU/L < 10 u IU/L) and with or without receiving on-going conventional medication for the same.
排除标准
- •1.Women with a partial or complete hysterectomy, tubal ligations history
- •2.Women who are pregnant or lactating
- •3.Smokers/Alcoholics and/or drug abusers
- •4.Patient with poorly controlled Hypertension
- •5.Patients with evidence of malignancy
- •6.Patients receiving any herbal, Ayurvedic, homeopathic, siddha or unani medicine for hypothyroidism
- •7.History or presence of any medical condition or disease according to the discretion of the Investigator
研究者
相似试验
进行中（未招募）
1 期
Clinical Study of CV-HFD01 tablets as Adjuvant Therapy in patients with Type 2 DM.CTRI/2019/04/018403Climic Health Pvt Ltd
已完成
1 期
This is phase one study with healthy adult participants to be enrolled to receive study product to check the safety and tolerability of liquid rotavirus vaccine in healthy adultsCTRI/2015/11/006384Serum Institute of India Limited20
已完成
不适用
Open-label clinical trial to evaluate the safety and efficacy of the investigational devices in total hip arthroplasty.Patients with hip joint disease caused by hip osteoarthritis and others.JPRN-UMIN000012433KYOCERA Medical Corporation20
进行中（未招募）
1 期
Clinical study to find out whether methylene blue injection is safe and effective in the treatment of a blood disorder (methemoglobinemia) resulting from exposure to toxic agents (drugs or environmental poisons)Acquired methemoglobinemiaMedDRA version: 20.0Level: LLTClassification code 10054290Term: Acquired methemoglobinemiaSystem Organ Class: 100000004851EUCTR2017-000290-37-GBProvepharm SAS10
进行中（未招募）
1 期
Clinical study to find out whether methylene blue injection is safe and effective in the treatment of a blood disorder (methemoglobinemia) resulting from exposure to toxic agents (drugs or environmental poisons)Acquired methemoglobinemiaMedDRA version: 20.0Level: LLTClassification code 10054290Term: Acquired methemoglobinemiaSystem Organ Class: 100000012871EUCTR2017-000290-37-FRProvepharm SAS10